Altasciences can provide a customized, end-to-end pathway for your drug development programs, from lead candidate selection through early phase clinical trials. Our platform enables biotechnology and pharmaceutical companies to work with a single, integrated partner to develop molecules through to human proof of concept. Minimizing handoffs throughout the process results in faster timelines and reduced costs.
Consult our Integrated Offering Overview
Our teams of toxicologists, clinical pharmacologists, doctors, bioanalytical principal investigators, and technical staff have a knowledge base that spans a wide range of compounds, study types, therapeutic areas, and routes of administration. We welcome all questions regarding guidance and services you may require to move your compound through the many milestones of drug development.
Your Altasciences program manager will serve as a single point of contact for the entire life of your program, helping your test article advance from one milestone to the next and proactively sharing your preferences across all of our operational groups. Our mantra is: Tell us once…
MOVING YOUR SMALL MOLECULE OR BIOLOGIC TOWARD REGULATORY APPROVAL
The process from lead molecule identification to approval can be long and complicated. Altasciences is here to help streamline and accelerate you through it.
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide comprehensive support research services and bioanalytical expertise.